tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

LIXT Stock Latest News

Lixte Biotechnology Raises $6.5M, Appoints New Management
Company AnnouncementsLixte Biotechnology Raises $6.5M, Appoints New Management
10d ago
8K
LIXT
Lixte Biotechnology provides update on recent corporate activities
PremiumThe Fly
Lixte Biotechnology provides update on recent corporate activities
11d ago
LIXT
Lixte Biotechnology Adopts Cryptocurrency in Treasury Policy
PremiumCompany Announcements
Lixte Biotechnology Adopts Cryptocurrency in Treasury Policy
15d ago
8K
LIXT
Lixte Biotechnology updates treasury policy to include cryptocurrency
PremiumThe Fly
Lixte Biotechnology updates treasury policy to include cryptocurrency
16d ago
LIXT
Lixte Biotechnology Regains Nasdaq Compliance After Fundraising
PremiumCompany Announcements
Lixte Biotechnology Regains Nasdaq Compliance After Fundraising
1M ago
8K
LIXT
Lixte regains compliance with Nasdaq’s Continued Listing requirements
PremiumThe FlyLixte regains compliance with Nasdaq’s Continued Listing requirements
1M ago
LIXT
Lixte’s LB100 Clinical Trials Validated by Nature
Premium
Company Announcements
Lixte’s LB100 Clinical Trials Validated by Nature
2M ago
8K
LIXT
Lixte Biotechnology announces publication in Nature journal on LB100 trials
Premium
The Fly
Lixte Biotechnology announces publication in Nature journal on LB100 trials
2M ago
LIXT
Lixte Biotechnology Closes $1.5M Direct Offering
PremiumCompany Announcements
Lixte Biotechnology Closes $1.5M Direct Offering
2M ago
8K
LIXT
Lixte Biotechnology Announces $5M Private Placement
PremiumCompany Announcements
Lixte Biotechnology Announces $5M Private Placement
2M ago
8K
LIXT
Lixte Biotechnology files to sell 5.26M shares of common stock, warrants
PremiumThe Fly
Lixte Biotechnology files to sell 5.26M shares of common stock, warrants
2M ago
LIXT
Lixte Biotechnology Converts Preferred Stock to Common
PremiumCompany Announcements
Lixte Biotechnology Converts Preferred Stock to Common
3M ago
8K
LIXT
Lixte Biotechnology files to sell 467,393 shares of common stock for holders
PremiumThe FlyLixte Biotechnology files to sell 467,393 shares of common stock for holders
5M ago
LIXT
Lixte Biotechnology launches new study in collaboration with NKI on LB-100
Premium
The Fly
Lixte Biotechnology launches new study in collaboration with NKI on LB-100
5M ago
LIXT
Lixte Biotechnology provides update on progress with LB-100
Premium
The Fly
Lixte Biotechnology provides update on progress with LB-100
5M ago
LIXT
Lixte announces online publication of new pre-clinical data in BioXriv
PremiumThe Fly
Lixte announces online publication of new pre-clinical data in BioXriv
6M ago
LIXT
Lixte Biotechnology adds Lurie Cancer Center as second site in LB-100 trial
PremiumThe Fly
Lixte Biotechnology adds Lurie Cancer Center as second site in LB-100 trial
6M ago
LIXT
Lixte Biotechnology announces closing of $1.05M registered direct offering
PremiumThe Fly
Lixte Biotechnology announces closing of $1.05M registered direct offering
7M ago
LIXT
Lixte to sell 434,784 shares at $2.415 in registered direct offering
PremiumThe Fly
Lixte to sell 434,784 shares at $2.415 in registered direct offering
7M ago
LIXT
Lixte Biotechnology requests withdrawal of registration statement
PremiumThe FlyLixte Biotechnology requests withdrawal of registration statement
7M ago
LIXT
Lixte Biotechnology files to sell units, no amount given
Premium
The Fly
Lixte Biotechnology files to sell units, no amount given
10M ago
LIXT
Lixte Biotechnology receives U.S. patent issue notification for Immune Oncology
Premium
The Fly
Lixte Biotechnology receives U.S. patent issue notification for Immune Oncology
12M ago
LIXT

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >